Articles tagged with Cancer Treatments
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
Researchers identify non-classical oncogenes critical for leukemia cell survival and develop a strategy targeting these molecules, potentially reducing toxicity of current treatments. Dual inhibition of PI3K subtypes supports cancer cell death in mice and human tumor cells.
Performing targeted swallowing exercises following chemoradiation therapy (CRT) for head and neck cancer improves swallowing function in the short term. However, this benefit does not last beyond three months, with no significant difference found at nine or 12 months post-treatment.
A study at Wake Forest Baptist Medical Center found that patients prefer immediate access to radiology test results, even for complex diagnoses. The study showed that about half of participants preferred instant access, while a third preferred access within three days.
A study at Fox Chase Cancer Center found that patients with a specific variant of the CYP1B1 gene have a longer time-to-recurrence of squamous cell carcinoma of the head and neck. This discovery could lead to tailored treatment approaches for affected individuals.
A new mathematical model predicts optimal treatment length for prostate cancer patients to delay resistance, allowing clinicians to tailor therapy effectively. Intermittent androgen suppression therapy reduces side effects and improves patient outcomes.
Researchers have identified a new protein, S100PBP, that suppresses cathepsin Z and reduces pancreatic cancer cells' ability to attach to other tissues. This discovery may lead to the development of novel preventive and therapeutic targets for pancreatic cancer.
Researchers are using pond scum microbes called Euglena to develop a new test for detecting cancer cells in the bloodstream. The test uses the microbe as a natural cargo carrier to identify and analyze circulating tumor cells, which enable cancer to spread.
Researchers have discovered a new mechanism of prostate cancer cell metabolism by identifying the PFKFB4 gene, which is vital for tumor growth and antioxidant production. The study found that depletion of this gene in laboratory models inhibited tumor growth, suggesting potential targeted therapies.
A Dutch study reveals that breast cancer screening and improved treatments together save a significant number of lives. The study found that adjuvant therapy reduced deaths by 13.9%, while two-yearly screening added another 15.7%. Combining both approaches resulted in a total reduction of 31.1% in breast cancer mortality.
Scientists have developed a new method for studying selenium metabolism in living organisms, which could help clarify the element's potential anti-tumor properties. The technique uses enriched stable isotopes to track selenium concentrations in biological tissues and fluids, revealing its presence and behavior in the body.
Researchers found that smoking restored depleted self-control resources in smokers, improving their mood and performance on frustrating tasks. This study suggests that nicotine can be a maladaptive way to cope with stress, and alternative strategies like relaxation or sugary drinks may be healthier options.
A recent study published in Cancer Research suggests that dietary cadmium may be associated with an increased risk of breast cancer. Women who consumed higher amounts of whole grain and vegetables had a lower risk of breast cancer compared to those exposed through other foods.
A new report estimates that broader screening for hepatitis C virus (HCV) would be cost-effective in reducing mortality and morbidity. The study recommends a one-time screening for all adults between 20 and 69 years old to identify those infected with the virus, which affects 4 million U.S. residents.
A new study suggests that broader screening for hepatitis C virus (HCV) would be cost effective in reducing related mortality and morbidity. The report emphasizes the importance of linking those infected with the treatment they need to prevent further complications.
A study by the Trudeau Institute has identified key mechanisms in controlling gamma-herpesvirus infections and their implications for treating and preventing cancer. Researchers found that immune responses differ between initial active phase and long-term latent infection phases.
Children treated for cancer before age 4 experience delays in vocabulary, cognitive functions, and motor skills compared to their healthy peers. However, social and emotional development remains unaffected.
Researchers will focus on inhibiting cancer cell metabolism by targeting Mct1 and Mct4 proteins, which transport lactic acid out of cancer cells. The goal is to develop broad-spectrum anti-cancer therapeutics for breast cancer and lymphoma.
Dr. Kari Alitalo receives the award for his outstanding contributions to lymphatic science and advancement of VEGF-C lymph node transplant research, which shows promise in treating lymphedema and improving lymphatic function.
Chinese Minister of Health Dr. Zhu Chen will hold talks with leading cancer researchers from the US and China to develop a stronger platform for Sino-US research collaboration. The goal is to fast-track cancer research and create deeper ties among researchers.
Researchers found that vitamin D reduced the size of uterine fibroids in laboratory rats by an average of 75% compared to untreated groups. This study provides promising evidence for vitamin D as a potential treatment for fibroids, which affect millions of women worldwide.
New research highlights the importance of nurses in alleviating concerns and existential issues in newly diagnosed lung cancer patients. Nurses can provide supportive care, address death-related concerns, and help patients locate resources to manage end-of-life affairs.
A UK study provides insight into the relationship between manganese superoxide dismutase (MnSOD) and cancer progression. The research found that MnSOD expression was suppressed early in skin carcinogenesis but increased at late stages, highlighting its role as a p53-regulated gene.
Professor Mike Stratton discusses the evolution of the cancer genome at the AAAS annual meeting, highlighting advances in whole genome sequencing and the development of COSMIC catalogue. This research provides insights into cancer causation, prevention, and treatment, with potential global solutions through international collaboration.
Researchers at Polytechnique Montréal developed a new transfection method that changes the genetic material of cancer cells, allowing for precise nanometric-scale surgery. This breakthrough could lead to new therapeutic approaches in oncology, neurology, and cardiology, with promising applications.
Malnourished cancer patients who received oral nutritional support showed improvements in aspects of quality of life, including emotional functioning and loss of appetite. However, the interventions had no impact on mortality rates or consistent effects on weight gain.
A new study published in The Lancet Oncology shows that cognitive behavioural therapy (CBT) significantly reduces hot flushes and night sweats in women after breast cancer treatment. CBT improves symptoms by 46-52% compared to usual care, with sustained benefits at 26 weeks.
Researchers at Stanford University have identified a sequential treatment regimen that enhances the effectiveness of trastuzumab in xenotransplant models of breast cancer. Trastuzumab activates natural killer cells to kill HER2-overexpressing tumor cells.
Researchers have discovered a new way to enhance trastuzumab treatment in HER2-positive breast cancer patients by stimulating natural killer cells. Additionally, the activation of FoxO1 has been linked to the development of diabetic cardiomyopathy, offering a promising therapeutic target. Leptin's direct action on POMC neurons may also...
Researchers at Thomas Jefferson University found that curcumin suppresses nuclear receptor activators, which can bypass androgen deprivation therapy. Curcumin also reduced cell number and inhibited survival in prostate cancer cells, with similar results seen in mice studies.
A study published by the NIH shows that Kineret therapy is effective in stopping the progression of organ damage in people with neonatal-onset multisystem inflammatory disease (NOMID). By preventing organ inflammation, scientists were able to preserve organ function in most patients.
Researchers found a gene, LTA4H, that influences inflammation to TB infection, predicting drug therapy effectiveness. This discovery suggests tailoring treatment based on patients' genetic sequences could improve patient outcomes.
Cancer tumors' metabolic profiles vary based on genes and tissue origin, necessitating individualized treatment approaches. The metabolome, in addition to the genome, is crucial for predicting metabolic changes and guiding therapy.
Researchers at LSU Health Sciences Center have identified a new protein called ARD1 that plays a critical role in the development and growth of prostate cancer. Inactivating this protein completely suppresses cancer growth, making it a potential target for new treatments.
A study published in Cancer Prevention Research found that soy isoflavone supplements did not decrease breast cancer cell proliferation. The results are consistent with previous studies on the effectiveness of dietary supplements in preventing cancer.
Glioblastoma multiforme (GBM) is a highly aggressive brain tumor resistant to current therapies. Researchers at the University of California, San Francisco, have identified PDGFR-alpha and SULF2 as potential therapeutic targets for GBM treatment. Knocking down SULF2 expression decreased cell growth in human GBM cell lines.
A study published in Science Translational Medicine found that massage reduces inflammation and promotes the growth of new mitochondria in skeletal muscle after intense exercise. The research provides evidence that massage could be a valuable treatment option for individuals with chronic inflammatory diseases or musculoskeletal injuries.
Researchers identify 'gatekeeper' ADAM17 involved in regulating immune response and preventing inflammatory skin disease. Reactivation of Notch signaling rescues local skin inflammation and abnormal immune cell proliferation.
A novel molecular process linked to neddylation has been found to be involved in the development of hepatocellular carcinoma, a type of liver cancer with poor prognosis. The study suggests that targeting this process could lead to potential therapeutic applications for patients with HCC.
Despite significant progress in treating chronic myeloid leukemia, a cure remains elusive for all patients. Research and adherence to treatments are crucial to advancing the field.
A study published in the Journal of the National Cancer Institute found that younger breast cancer patients experience more severe mental health issues and physical impairments than older women. Researchers recommend educating these patients about potential post-treatment effects to reduce anxiety and improve quality of life.
A UCSF team has developed methods to reveal a molecular marker in tissue samples from brain tumors that has been linked to better survival odds. Monitoring this marker could provide doctors with a better way to follow their patients after surgery and assess how they respond to recommended treatments.
Researchers used human embryonic stem cells to treat macular degeneration in two patients, with some improvement in vision observed. The study showed that the transplants were safe and led to successful engraftment of cells into the retina.
A study published in the Journal of the National Cancer Institute found that younger women with breast cancer experience decreased health-related quality of life, including increased psychological distress, weight gain, and early onset menopause. Personalized treatment approaches are crucial to mitigate these side effects.
Researchers at Dana-Farber Cancer Institute discovered a mechanism by which micronuclei disrupt chromosomes, leading to cancer-causing gene mutations. The findings suggest that whole chromosome aneuploidy may promote cancer in a similar way to other genomic alterations.
A new study found that poor smokers are more likely to relapse after quitting, with those on lower rungs of the socioeconomic ladder facing the toughest odds. The research suggests that financial difficulties, discrimination, and job insecurity contribute to their struggle.
Researchers developed a new combination drug therapy that successfully suppressed hepatitis C genotype 1 infection in a significant proportion of patients. The study, published in the New England Journal of Medicine, focused on treating patients who had not responded to previous treatment with PEG-interferon alfa and ribavirin.
Researchers have identified a novel connection between two RNA-binding proteins, Musashi1 and HuR, which plays a significant role in glioblastoma development. The study suggests that disruptions to these regulatory processes can contribute to tumor formation.
Researchers at Columbia University Irving Medical Center identified the origin of esophageal adenocarcinoma as the gastric cardia, where bile acid and inflammatory cytokines activate stem cells. The study highlights possible targets for new clinical therapies, including inhibiting notch signaling.
A retrospective analysis of 1,500 patients showed that live interactive teledermatology consultations resulted in diagnostic changes for nearly 70% of patients. Patients also received recommendations to change their skin disease management, leading to improved clinical outcomes.
Researchers at UBC have found a way to block infection from the hepatitis C virus (HCV) in the liver, leading to new therapies for those affected by this and other infectious diseases. The approach could benefit millions of people globally.
Research finds that multicentric lung adenocarcinoma often shares the same genetic mutation, indicating a possible common origin for these tumors. The study identified genetically distinct molecular subsets using EGFR and KRAS genes.
Researchers found sorafenib to be effective in patients with non-small cell lung cancer and a KRAS mutation, achieving a 52.6% rate of no progression at six weeks. However, median overall survival was only 5.3 months, indicating unsatisfactory outcomes.
A University of Illinois study found that personalized prognostic tools and gene-based therapies can improve the survival and quality of life of glioblastoma patients. The researchers discovered new general and clinical-dependent gene profiles that can be used to predict patient outcomes and select targeted therapies.
A new study explores the fertility and parenthood concerns of young female cancer survivors, finding that they are often unaware of the impact of treatment on their future fertility. The researchers identified six themes from focus group discussions, highlighting the need for better information, continuity of care, and guidance to addr...
A prospective surveillance model for breast cancer treatment has been shown to significantly reduce costs and improve outcomes. The model, which involves early identification and intervention of lymphedema-related impairment, has been associated with direct treatment costs of $636.19 per year compared to traditional care at $3,124.92.
The Damon Runyon Cancer Research Foundation and the Sohn Conference Foundation have partnered to support young scientists tackling childhood cancers, with a focus on preventing devastating illnesses in children and young adults. The partnership aims to recruit top young minds to research childhood cancers, leveraging the success of exi...
Most patients who survive oesophageal cancer surgery recover an average quality of life, but one in six experience significant deterioration. Hospitals must improve identification and follow-up for these patients to prevent persistently low quality of life.
A new study shows that targeting a specific microRNA, miR-221, can prolong the lives of mice with human liver cancer. The treatment also boosted activity of tumor-suppressor genes in these animals.
Researchers have identified mutations in the ATM gene as a potential risk factor for increased pancreatic cancer risk. Studies found that ATM gene mutations were present in four of 166 patients with pancreatic cancer, but absent in healthy spousal controls.
The study reveals a DNA repair mechanism that can mitigate oxidative damage, which is linked to various diseases including cancer and Alzheimer's. This discovery holds promise for developing less invasive cancer therapies and early detection tests.